Jason A. Leverone
CIK 1692747 · Chief Financial Officer · last filed 2026-04-03
Jason A. Leverone is a Chief Financial Officer who has filed 18 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for OKUR, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$12.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $67.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$67.2K
3
18
-$12.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKUR | Chief Financial Officer | 16,000 | $4.20 | $67.2K | -$12.8K | 8 | 2026-04-03 |
| VRDN | Chief Financial Officer | — | $16.35 | — | $0 | 1 | 2021-01-20 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | CFO, Treasurer & Secretary | 48,829 | — | — | $0 | 9 | 2020-03-17 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2026-03-24 | OKUR | Sell (S) | −301 | -$1.3K | EDGAR |
| 2025-12-23 | OKUR | Sell (S) | −302 | -$896 | EDGAR |
| 2025-09-24 | OKUR | Sell (S) | −303 | -$795 | EDGAR |
| 2025-06-25 | OKUR | Sell (S) | −303 | -$722 | EDGAR |
| 2025-04-08 | OKUR | Sell (S) | −3,122 | -$9.2K | EDGAR |
| 2025-01-29 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2024-10-08 | OKUR | Grant (A) | +16,331 | $0 | EDGAR |
| 2021-01-20 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2020-03-17 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Exer (M) | +11,249 | $6.4K | EDGAR |